Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Short-chain fatty acid metabolism" refers to the collective biochemical processes by which short-chain fatty acids (SCFAs)—primarily acetate, propionate, and butyrate—are produced and utilized in the body. These SCFAs are generated mainly through microbial fermentation of dietary fibers in the colon[1][3][5]. They serve as key energy sources for colonocytes, regulate glucose and lipid homeostasis, modulate appetite via gut hormones such as GLP1 and PYY, influence immune responses by promoting T regulatory cell differentiation and cytokine production, enhance intestinal barrier function by supporting tight junction assembly, and play a role in maintaining overall intestinal health[1][2][3][4][5]. SCFA signaling is mediated through G protein-coupled receptors such as GPR41/43 on various cell types[4]. Altered SCFA levels or dysregulated metabolism have been implicated in diseases including metabolic syndrome, inflammatory bowel disease, neurodegenerative conditions via the gut-brain axis connection, and certain cancers[1][2][3]. Note: "Short-chain fatty acid metabolism" is not a single molecule or receptor but rather a metabolic process involving multiple enzymes/pathways. It is not considered a canonical therapeutic target like an enzyme or receptor; instead it describes a physiological system/process. If you are seeking information about specific molecular targets within this pathway—such as G protein-coupled receptors for SCFAs (GPR41/FFAR3 or GPR43/FFAR2), transporters like MCTs (monocarboxylate transporters), or enzymes involved in their synthesis/utilization—those should be specified individually for structured data extraction[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Short-chain fatty acid metabolism.